HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Naïg Gueguen Selected Research

Type 2K Charcot-Marie-Tooth disease

1/2020Oxidative stress contributes differentially to the pathophysiology of Charcot-Marie-Tooth disease type 2K.
4/2009Mitochondrial complex I deficiency in GDAP1-related autosomal dominant Charcot-Marie-Tooth disease (CMT2K).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Naïg Gueguen Research Topics

Disease

5Autosomal Dominant Optic Atrophy (Dominant Optic Atrophy)
06/2020 - 06/2008
4Leber Hereditary Optic Atrophy (Leber's Hereditary Optic Neuropathy)
04/2020 - 06/2008
3Optic Nerve Diseases (Optic Neuropathy)
01/2021 - 03/2010
2Neoplasms (Cancer)
11/2021 - 08/2021
2Breast Neoplasms (Breast Cancer)
11/2021 - 08/2021
2Type 2K Charcot-Marie-Tooth disease
01/2020 - 04/2009
2Acute Intermittent Porphyria (Porphyria, Acute)
09/2015 - 06/2014
2Body Weight (Weight, Body)
11/2009 - 05/2002
1Mitochondrial Diseases (Mitochondrial Disease)
12/2021
1Lactic Acidosis
12/2021
1Hypoxia (Hypoxemia)
08/2021
1Retinal Degeneration
01/2021
1Spinocerebellar ataxia 28
06/2020
1Hereditary Spastic Paraplegia
06/2020
1Hyperhomocysteinemia
01/2020
1Muscle Weakness
01/2020
1Disease Progression
01/2020
1Anemia
09/2018
1Iron Deficiencies
09/2018
1Heart Failure
09/2018
1Metabolic Diseases (Metabolic Disease)
09/2015
1Neurodegenerative Diseases (Neurodegenerative Disease)
01/2015
1Type 2A Charcot-Marie-Tooth disease
05/2011
1Peripheral Nervous System Diseases (PNS Diseases)
05/2011
1Tuberculosis (Tuberculoses)
03/2010
1Inherited Peripheral Neuropathy
02/2010
1Deafness (Deaf Mutism)
10/2009
1Atrophy
05/2009
1Muscular Atrophy (Muscle Atrophy)
05/2009
1Type 4A Charcot-Marie-Tooth disease
04/2009
1Charcot-Marie-Tooth Disease (Peroneal Muscular Atrophy)
04/2009
1Cataract (Cataracts)
06/2008

Drug/Important Bio-Agent (IBA)

5Mitochondrial DNA (mtDNA)IBA
04/2020 - 06/2008
2Doxorubicin (Adriamycin)FDA LinkGeneric
11/2021 - 08/2021
2ResveratrolIBA
01/2020 - 01/2015
2GTP Phosphohydrolases (GTPases)IBA
01/2017 - 10/2009
2Heme (Haem)IBA
09/2015 - 06/2014
2Hydroxymethylbilane Synthase (Porphobilinogen Deaminase)IBA
09/2015 - 06/2014
2EnzymesIBA
06/2014 - 05/2002
2Proteins (Proteins, Gene)FDA Link
02/2010 - 04/2009
1Lactic Acid (Lactate)FDA LinkGeneric
12/2021
1Protons (Proton)IBA
12/2021
1Oxygen (Dioxygen)IBA
12/2021
1acetoacetic acid (acetoacetate)IBA
12/2021
1Long Noncoding RNAIBA
11/2021
1Reactive Oxygen Species (Oxygen Radicals)IBA
08/2021
1Aconitate Hydratase (Aconitase)IBA
01/2021
1m-AAA proteasesIBA
06/2020
1Protein SIBA
04/2020
1Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA
01/2020
1Glutathione Transferase (Glutathione S-Transferase)IBA
01/2020
1IronIBA
09/2018
1SpermidineIBA
11/2016
1propionylcarnitineIBA
11/2016
1Phosphatidylcholines (Phosphatidylcholine)IBA
11/2016
1Amino AcidsFDA Link
11/2016
1SphingomyelinsIBA
11/2016
1PutrescineIBA
11/2016
1Carnitine (L-Carnitine)FDA LinkGeneric
11/2016
1Membrane Proteins (Integral Membrane Proteins)IBA
05/2011
1Ethambutol (Myambutol)FDA LinkGeneric
03/2010
1Pharmaceutical PreparationsIBA
03/2010
1RimonabantIBA
11/2009
1Dynamins (Dynamin)IBA
10/2009
1Thyroid Hormone Receptors (Thyroid Hormone Receptor)IBA
05/2009
1Proteasome Endopeptidase Complex (Proteasome)IBA
05/2009
1UbiquitinIBA
05/2009
1Ligases (Synthetase)IBA
05/2009
1Adenosine Triphosphatases (ATPase)IBA
05/2002

Therapy/Procedure

1Drug Therapy (Chemotherapy)
11/2021